- Z79.61 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM Z79.61 became effective on October 1, 2022.
- This is the American ICD-10-CM version of Z79.61 – other international versions of ICD-10 Z79.61 may differ.
Applicable To
- Long term (current) use of apremilast
- Long term (current) use of immunomodulatory imide drug
- Long term (current) use of lenalidomide
- Long term (current) use of pomalidomide
Code History
- 2024 (effective 10/1/2022): New code
- 2024 (effective 10/1/2022): No change